Gastro-oesophageal reflux disease in 20 dogs (2012 to 2014)

J Small Anim Pract. 2017 May;58(5):276-283. doi: 10.1111/jsap.12646. Epub 2017 Feb 24.

Abstract

Objectives: To describe the clinical features of canine gastro-oesophageal reflux disease.

Materials and methods: A search of our medical records produced 20 dogs with clinical signs attributable to oesophageal disease, hyper-regeneratory oesophagopathy and no other oesophageal disorders. The clinical, endoscopic and histological findings of the dogs were analysed.

Results: The 3-year incidence of gastro-oesophageal reflux disease was 0·9% of our referral dog population. Main clinical signs were regurgitation, discomfort or pain (each, 20/20 dogs) and ptyalism (18/20 dogs). Oesophagoscopy showed no (5/20 dogs) or minimal (13/20 dogs) mucosal lesions. In oesophageal mucosal biopsy specimens, there were hyperplastic changes of the basal cell layer (13/20 dogs), stromal papillae (14/20 dogs) and entire epithelium (9/20 dogs). Eleven dogs received omeprazole or pantoprazole and regurgitation and ptyalism improved in eight and pain diminished in six of these dogs within three to six weeks.

Clinical significance: Our findings suggest that canine gastro-oesophageal reflux disease is a more common clinical problem than hitherto suspected.

MeSH terms

  • Animals
  • Dog Diseases / epidemiology*
  • Dog Diseases / pathology
  • Dogs
  • Esophagoscopy / veterinary*
  • Female
  • Gastroesophageal Reflux / epidemiology
  • Gastroesophageal Reflux / pathology
  • Gastroesophageal Reflux / veterinary*
  • Male
  • Omeprazole / therapeutic use

Substances

  • Omeprazole